Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer. Jackisch C, Barcenas CH, Bartsch R, Palma JD, et al. Clin Breast Cancer 2021 Feb 6. pii: S1526-8209(21)00043.

Read + Share

Amedeo Smart

Independent Medical Education

Jackisch C, Barcenas CH, Bartsch R, Palma JD, et al. Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer. Clin Breast Cancer 2021 Feb 6. pii: S1526-8209(21)00043.
PMID: 33678567